Serum omentin levels predicts mesenteric ischemia.

Area of Science:

• Vascular Surgery
• Gastroenterology
• Metabolic Research

Background:

• Acute mesenteric ischemia (AMI) presents diagnostic challenges and high mortality.
• Omentin, a visceral adipose tissue protein, is linked to metabolic health.
• Decreased serum omentin correlates with adverse metabolic outcomes.

Purpose of the Study:

• To investigate if serum omentin levels can predict early AMI.
• To assess omentin's role before transmural ischemia develops.

Main Methods:

• A rat model with sham, transient ischemia, and permanent ischemia groups (n=8 each).
• Serum analysis for urea, creatinine, omentin, and C-reactive protein (CRP).
• Histological examination of ileal tissue.

Main Results:

• Serum omentin levels were significantly lower in the ischemia-reperfusion group compared to the sham group (p=0.004).
• No correlation was found between serum omentin and urea, creatinine, or CRP levels.

Conclusions:

• Serum omentin may serve as a potential biochemical marker for early AMI detection.
• Further clinical studies in humans are required to validate these findings.